Cargando…
Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma
The transcription factor BarH-like homeobox 2 (BARX2), a member of the Bar-like homeobox gene family, is involved in cell proliferation, differentiation, immune responses and tumorigenesis. However, the potential role of BARX2 in the development of liver hepatocellular carcinoma (LIHC) remains uncle...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170086/ https://www.ncbi.nlm.nih.gov/pubmed/37161008 http://dx.doi.org/10.1038/s41598-023-34519-8 |
_version_ | 1785039165315874816 |
---|---|
author | Yu, Shian Yang, Yu Yang, Hanqing Peng, Long Wu, Zhipeng Sun, Liang Wu, Zhengyi Yu, Xuzhe Yin, Xiangbao |
author_facet | Yu, Shian Yang, Yu Yang, Hanqing Peng, Long Wu, Zhipeng Sun, Liang Wu, Zhengyi Yu, Xuzhe Yin, Xiangbao |
author_sort | Yu, Shian |
collection | PubMed |
description | The transcription factor BarH-like homeobox 2 (BARX2), a member of the Bar-like homeobox gene family, is involved in cell proliferation, differentiation, immune responses and tumorigenesis. However, the potential role of BARX2 in the development of liver hepatocellular carcinoma (LIHC) remains unclear. Therefore, we aimed to study the biological role of BARX2 in hepatocellular carcinoma. Through the UALCAN, GTEx PORTAL, TIMER 2.0, LinkedOmics, SMART, MethSurv, Metascape, GSEA and STRING public databases, the BARX2 mRNA level, prognostic value, coexpressed genes, associated differentially expressed genes, DNA methylation and functional enrichment of LIHC patients were studied. The relationships between BARX2 expression and various clinical or genetic parameters of LIHC patients were determined using data from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and BEAT LIHC databases. In addition, the biological function of BARX2 in LIHC was studied in vitro. Through large-scale data mining, our study showed that BARX2 was differentially expressed between different normal and tumour tissues.BARX2 expression in LIHC tissues was significantly lower than that in corresponding controls, especially in patients with T2-4 stage disease. In patients with LIHC, overexpression of BARX2 was an independent poor prognostic factor associated with poor cytogenetic risk and gene mutations. Genomic hypermethylation of the BARX2 gene was associated with upregulated BARX2 expression and poor overall survival (OS) in LIHC. Functional enrichment analysis showed that BARX2 had an immunomodulatory role and was involved in the inflammatory response in LIHC occurrence. In conclusion, the oncogene BARX2 may serve as a new biomarker and prognostic factor for patients with LIHC. The immunomodulatory function of BARX2 deserves further validation in LIHC. |
format | Online Article Text |
id | pubmed-10170086 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-101700862023-05-11 Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma Yu, Shian Yang, Yu Yang, Hanqing Peng, Long Wu, Zhipeng Sun, Liang Wu, Zhengyi Yu, Xuzhe Yin, Xiangbao Sci Rep Article The transcription factor BarH-like homeobox 2 (BARX2), a member of the Bar-like homeobox gene family, is involved in cell proliferation, differentiation, immune responses and tumorigenesis. However, the potential role of BARX2 in the development of liver hepatocellular carcinoma (LIHC) remains unclear. Therefore, we aimed to study the biological role of BARX2 in hepatocellular carcinoma. Through the UALCAN, GTEx PORTAL, TIMER 2.0, LinkedOmics, SMART, MethSurv, Metascape, GSEA and STRING public databases, the BARX2 mRNA level, prognostic value, coexpressed genes, associated differentially expressed genes, DNA methylation and functional enrichment of LIHC patients were studied. The relationships between BARX2 expression and various clinical or genetic parameters of LIHC patients were determined using data from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and BEAT LIHC databases. In addition, the biological function of BARX2 in LIHC was studied in vitro. Through large-scale data mining, our study showed that BARX2 was differentially expressed between different normal and tumour tissues.BARX2 expression in LIHC tissues was significantly lower than that in corresponding controls, especially in patients with T2-4 stage disease. In patients with LIHC, overexpression of BARX2 was an independent poor prognostic factor associated with poor cytogenetic risk and gene mutations. Genomic hypermethylation of the BARX2 gene was associated with upregulated BARX2 expression and poor overall survival (OS) in LIHC. Functional enrichment analysis showed that BARX2 had an immunomodulatory role and was involved in the inflammatory response in LIHC occurrence. In conclusion, the oncogene BARX2 may serve as a new biomarker and prognostic factor for patients with LIHC. The immunomodulatory function of BARX2 deserves further validation in LIHC. Nature Publishing Group UK 2023-05-09 /pmc/articles/PMC10170086/ /pubmed/37161008 http://dx.doi.org/10.1038/s41598-023-34519-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Yu, Shian Yang, Yu Yang, Hanqing Peng, Long Wu, Zhipeng Sun, Liang Wu, Zhengyi Yu, Xuzhe Yin, Xiangbao Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma |
title | Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma |
title_full | Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma |
title_fullStr | Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma |
title_full_unstemmed | Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma |
title_short | Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma |
title_sort | pancancer analysis of oncogenic barx2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170086/ https://www.ncbi.nlm.nih.gov/pubmed/37161008 http://dx.doi.org/10.1038/s41598-023-34519-8 |
work_keys_str_mv | AT yushian pancanceranalysisofoncogenicbarx2identifyingitsprognosticvalueandimmunologicalfunctioninliverhepatocellularcarcinoma AT yangyu pancanceranalysisofoncogenicbarx2identifyingitsprognosticvalueandimmunologicalfunctioninliverhepatocellularcarcinoma AT yanghanqing pancanceranalysisofoncogenicbarx2identifyingitsprognosticvalueandimmunologicalfunctioninliverhepatocellularcarcinoma AT penglong pancanceranalysisofoncogenicbarx2identifyingitsprognosticvalueandimmunologicalfunctioninliverhepatocellularcarcinoma AT wuzhipeng pancanceranalysisofoncogenicbarx2identifyingitsprognosticvalueandimmunologicalfunctioninliverhepatocellularcarcinoma AT sunliang pancanceranalysisofoncogenicbarx2identifyingitsprognosticvalueandimmunologicalfunctioninliverhepatocellularcarcinoma AT wuzhengyi pancanceranalysisofoncogenicbarx2identifyingitsprognosticvalueandimmunologicalfunctioninliverhepatocellularcarcinoma AT yuxuzhe pancanceranalysisofoncogenicbarx2identifyingitsprognosticvalueandimmunologicalfunctioninliverhepatocellularcarcinoma AT yinxiangbao pancanceranalysisofoncogenicbarx2identifyingitsprognosticvalueandimmunologicalfunctioninliverhepatocellularcarcinoma |